Background: A small randomized controlled trial suggested that dabigatran may be as
effective as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to …

Background Atrial fibrillation (AF) remains the most common form of cardiac arrhythmia.
Management of AF aims to reduce the risk of stroke, heart failure and premature mortality via …

There is increasing evidence that early and comprehensive removal of thrombus in deep
vein thrombosis is associated with improved outcomes, including decreased incidence of …

Background: Direct oral anticoagulants are first-line therapy for common thrombotic
conditions, including atrial fibrillation and venous thromboembolism. Despite their strong …

Aim Recent studies have compared the efficacy and safety of direct-acting oral
anticoagulants (DOAC) and low-molecular-weight heparin (LMWH) for cancer-associated …

Background Recently, direct oral anticoagulants (DOACs) have been included in guidelines
for the treatment of cancer-associated thrombosis (CAT) to be extended to suitable cancer …

Objectives To evaluate safety, efficacy, and feasibility of apixaban for postoperative venous
thromboembolism (VTE) prophylaxis following open gynecologic cancer surgery at a …

Background Over 6 million people in the United States require anticoagulation. Current
guidelines recommend direct oral anticoagulants (DOACs) over warfarin for select …

Background and objectives: Venous thromboembolism (VTE) represents a health and
economic burden with consequent healthcare resource utilization. Direct oral anticoagulants …

Background Cancer associated venous thromboembolism (VTE) is associated with
significant morbidity and mortality. Direct oral anticoagulants (DOACs) have emerged as …